Human Insulin Market: Information by Type (Traditional Human Insulin (Premixed Traditional, Intermediate Acting and Short-Acting), Modern Human Insulin (Premixed Modern, Long-Acting and Rapid Acting) and Brand (Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin and Insuman)) - Forecast till 2030
ID: MRFR/Pharma/0445-CR | February, 2021 | Region : Global
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Trends & Assessment
5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunities
6 Human Insulin Market, by Type
6.1 Introduction
6.2 Traditional Human Insulin
6.2.1 Premixed Traditional
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Intermediate Acting
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.3 Short Acting
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Modern Human Insulin
6.3.1 Premixed Modern
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2 Long Acting
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.3 Rapid Acting
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7 Human Insulin Market, by Brand
7.1 Introduction
7.2 Lantus
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Novorapid
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4 Humalog
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.5 Novomix
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.6 Levemir
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.7 Apidar
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.8 Humulin
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.9 Insuman
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8 Global Human Insulin Market, by Region
8.1 Introduction
8.2 Americas
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.2.1 North America
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.2.1.1 US
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.2.1.2 Canada
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.2.2 South America
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3 Europe
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.1 Western Europe
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.1.1 Germany
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.1.2 France
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.1.3 Italy
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.1.4 Spain
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.1.5 UK
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.1.6 Rest of Western Europe
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.3.2 Eastern Europe
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.4 Asia-Pacific
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.4.1 Japan
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.4.2 China
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.4.3 India
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.4.4 Australia
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.4.5 South Korea
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.4.6 Rest of Asia-Pacific
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.5 Middle East & Africa
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.5.1 Middle East
Human Insulin Market, by Type
Human Insulin Market, by Brand
8.5.2 Africa
Human Insulin Market, by Type
Human Insulin Market, by Brand
9 Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
10 Company Profiles
10.1 ADOCIA
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 MERCK & CO., INC.
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Julphar
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Pfizer Inc.
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Bristol-Myers Squibb Company
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 GLAXOSMITHKLINE PLC
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 SANOFI
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Oramed
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Novo Nordisk India Pvt. Ltd
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 Eli Lilly and Company
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 BIOCON
10.11.1 Overview
10.11.2 Product Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.12 Tonghua Dongbao Pharmaceutical Co., Ltd
10.12.1 Overview
10.12.2 Product Overview
10.12.3 Financials
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.13 Others
11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the global Human Insulin market
12 Appendix
13 LIST OF TABLES
Table 1 Human Insulin Market Synopsis, 2020–2027
Table 2 Human Insulin Market Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Human Insulin Market, by Region, 2020–2027 (USD Million)
Table 4 Global Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 5 Global Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 6 North America: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 7 North America: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 8 US: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 9 US: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 10 Canada: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 11 Canada: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 12 South America: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 13 South America: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 14 Europe: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 15 Europe: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 16 Western Europe: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 17 Western Europe: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 18 Eastern Europe: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 19 Eastern Europe: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 20 Asia-Pacific: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 21 Asia-Pacific: Human Insulin Market, by Brand, 2020–2027 (USD Million)
Table 22 Middle East & Africa: Human Insulin Market, by Type, 2020–2027 (USD Million)
Table 23 Middle East & Africa: Human Insulin Market, by Brand, 2020–2027 (USD Million)
14 LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Human Insulin Market
Figure 3 Market Dynamics for Global Human Insulin Market
Figure 4 Human Insulin Market Share, by Type, 2020
Figure 5 Human Insulin Market Share, by Brand, 2020
Figure 6 Human Insulin Market Share, by Region, 2020
Figure 7 North America: Human Insulin Market Share, by Country, 2020
Figure 8 Europe: Human Insulin Market Share, by Country, 2020
Figure 9 Asia-Pacific: Human Insulin Market Share, by Country, 2020
Figure 10 Middle East & Africa: Human Insulin Market Share, by Region, 2020
Figure 11 Human Insulin Market: Company Share Analysis, 2020 (%)
Figure 12 ADOCIA: Key Financials
Figure 13 ADOCIA: Segmental Revenue
Figure 14 ADOCIA: Geographical Revenue
Figure 15 MERCK & CO., INC.: Key Financials
Figure 16 MERCK & CO., INC.: Segmental Revenue
Figure 17 MERCK & CO., INC.: Geographical Revenue
Figure 18 Julphar: Key Financials
Figure 19 Julphar: Segmental Revenue
Figure 20 Julphar: Geographical Revenue
Figure 21 Pfizer Inc.: Key Financials
Figure 22 Pfizer Inc.: Segmental Revenue
Figure 23 Pfizer Inc.: Geographical Revenue
Figure 24 Bristol-Myers Squibb Company: Key Financials
Figure 25 Bristol-Myers Squibb Company: Segmental Revenue
Figure 26 Bristol-Myers Squibb Company: Geographical Revenue
Figure 27 GLAXOSMITHKLINE PLC: Key Financials
Figure 28 GLAXOSMITHKLINE PLC: Segmental Revenue
Figure 29 GLAXOSMITHKLINE PLC: Geographical Revenue
Figure 30 Oramed: Key Financials
Figure 31 Oramed: Segmental Revenue
Figure 32 Oramed: Geographical Revenue
Figure 33 Novo Nordisk India Pvt Ltd: Key Financials
Figure 34 Novo Nordisk India Pvt Ltd: Segmental Revenue
Figure 35 Novo Nordisk India Pvt Ltd: Geographical Revenue
Figure 36 Eli Lilly and Company: Key Financials
Figure 37 Eli Lilly and Company: Segmental Revenue
Figure 38 Eli Lilly and Company: Geographical Revenue
Figure 39 SANOFI: Key Financials
Figure 40 SANOFI: Segmental Revenue
Figure 41 SANOFI: Geographical Revenue
Figure 42 BIOCON: Key Financials
Figure 43 BIOCON: Segmental Revenue
Figure 44 BIOCON: Geographical Revenue
Figure 45 Tonghua Dongbao Pharmaceutical Co., Ltd.: Key Financials
Figure 46 Tonghua Dongbao Pharmaceutical Co., Ltd.: Segmental Revenue
Figure 47 Tonghua Dongbao Pharmaceutical Co., Ltd.: Geographical Revenue
